CONTEXT: Commercial announcement from Biodesix and Datavant to enhance their current lung cancer specific RWD biobank. It is hoped that the enhanced datasets will help pin future NSCLC treatments. IMPACT: Continue Reading
CONTEXT: Report of two abstracts presented by Lucence at ASCO 2021 detailing their molecular profiling of advanced cancers in a real-world setting using a liquid biopsy assay and results of Continue Reading
CONTEXT: A philanthropy-fuelled database created at the University of Calgary is proving its value and attracting international attention, including for some highly encouraging new research for treating lung cancer (NSCLC) | Cananda only data Continue Reading
CONTEXT: Report of a paper published in Immunotherapy, May 26th 2021 edition describing RWE study of PD-L1 testing patterns and treatment distribution in patients with NSCLC in Israel. The results Continue Reading
CONTEXT: On the back of previous news stories about genetic biomarker testing in NSCLC, Neogenomics announces the launch of KRAS G12C testing to eligible advanced / late stage NSCLC cancer Continue Reading
